MedAlliance SELUTION SLR is the first DEB to receive coronary ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GENEVA, Jan. 11, 2023 /PRNewswire-Asianet/ SELUTION SLR(TM), MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.This com...
Authors: LATEST ASIANET NEWS RELEASES